AstraZeneca's $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulatorMarket Watch • 05/25/21
AstraZeneca £27.5bn acquisition of Alexion under investigation by competition watchdogProactive Investors • 05/25/21
Coronavirus vaccines: UK hits 60mln doses milestone as new study proves AstraZeneca, Pfizer/BioNTech jabs work against Indian variantProactive Investors • 05/24/21
Japan Approves AstraZeneca's COVID Vaccine, But Puts Use on Hold Amid Blood Clot ConcernBenzinga • 05/21/21
AstraZeneca and Moderna receive approval for COVID-19 vaccines in JapanProactive Investors • 05/21/21
AstraZeneca ASCO 2021 Data Support Ambition to Revolutionize Cancer Outcomes by Treating Earlier and Transforming the Patient ExperienceBusiness Wire • 05/19/21
New Five-Year Data Shows Durable Efficacy Of AstraZeneca's Fasenra For Asthma TreatmentBenzinga • 05/19/21
Oxford/AstraZeneca Third Booster Strong Enough Against COVID-19 Variants, Study Shows: FTBenzinga • 05/19/21
LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership AppointmentsPRNewsWire • 05/19/21
Oxford BioMedica To Manufacture More Doses Of AstraZeneca's COVID-19 Vaccine, Upgrades 2021 OutlookBenzinga • 05/18/21
Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for manufacture of COVID-19 VaccineGlobeNewsWire • 05/18/21
Oxford Biomedica doubles financial guidance after AstraZeneca increases COVID-19 vaccine productionProactive Investors • 05/18/21
Mixing Pfizer and AstraZeneca Vaccines Increases Mild Side Effects but Is Safe, Study ShowsBarrons • 05/13/21
Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study showsMarket Watch • 05/13/21